Home
Ron Bentsur, Chairman & CEO: Nuvectis Pharma NVCT Buy · Filed 24/12/26
Trade details
- Type
- Insider buy
- Amount
- $20,925
- Shares · price
- 4,500 sh · $4.65 a share
- Held after
- 3,270,924 sh
- Stock
- Nuvectis Pharma NVCT
- Trade date
- 24/12/24
- Filed
- 24/12/26
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 1 insiders
- Holding change
- +0.1%
Nuvectis Pharma trades, last 26 weeks
What else happened in Nuvectis Pharma around then
Filed or reported within 30 days of the trade day · 24/11/24~25/01/23Ron Bentsur's recent trades
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$28.6K
5,000 sh
$28.6K
Filed 25/11/06
Traded 25/11/05
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$98.4K
20,000 sh
$98.4K
Filed 24/11/18
Traded 24/11/15
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$13.1K
1,940 sh
$13.1K
Filed 24/05/15
Traded 24/05/14
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$12.8K
2,000 sh
$12.8K
Filed 24/05/13
Traded 24/05/10
- Ron Bentsur
BuyNuvectis Pharma
BuyNuvectis Pharma
NVCT
$51.5K
5,000 sh
$51.5K
Filed 24/03/19
Traded 24/03/18